Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 16th November 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall for Clindacutin Ointment
Dechra Regulatory B.V has issued a class III recall to the wholesale level.

The product has been manufactured according to the specifications of Dutch marketing authorisation.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall for all in-date batches of Clindacutin Ointment 10mg/g.

In a news release, the VMD writes: “We wish to make wholesalers and distributors aware that all in-date batches of Clindacutin Ointment 10 mg/g (Vm 50406/4011) are being recalled with immediate effect.

“Dechra Regulatory B.V has issued a class III recall to the wholesale level.

“The reason for the recall is that the product has been manufactured released according to specifications of the Dutch marketing authorisation which is not approved in this country.” 

The recall is for the following batches only BC (21H258) expiry date July 2023, and BB (21H244) expiry date July 2023.

Dechra Regulatory B.V is contacting wholesale dealers to examine inventory immediately and quarantine any products subject to recall. 

For more information please contact quality@dechra.com or externalnetwork.qa@dechra.com 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'